Reports for IRBESARTAN

Active Ingredient

IRBESARTAN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AVAPRO 150MG TABLET Resolved 2019-10-09 2020-01-24 95797
AVAPRO 300MG TABLET Resolved 2019-02-08 2019-03-29 75171
AVAPRO 300MG TABLET Resolved 2019-07-16 2019-11-05 89476
AVAPRO 300MG TABLET Resolved 2019-11-29 2020-01-24 100061
AVAPRO 300MG TABLET Actual shortage 2020-03-12 2020-03-12 108533
AVALIDE 12.5MG 150MG TABLET Resolved 2018-12-20 2019-02-27 70230
AVALIDE 12.5MG 150MG TABLET Resolved 2019-10-09 2020-01-24 95800
AVALIDE 12.5MG 300MG TABLET Resolved 2019-02-08 2019-03-02 75166
AVALIDE 12.5MG 300MG TABLET Resolved 2019-05-08 2019-05-10 83440
AVALIDE 12.5MG 300MG TABLET Resolved 2019-07-16 2020-01-24 89482

Showing 1 to 10 of 172

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
ACT IRBESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65068
ACT IRBESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65071
ACT IRBESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65074
MYLAN-IRBESARTAN 300MG TABLET Discontinued 2017-08-24 2017-10-03 20271
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769

Showing 1 to 10 of 22